RATE AND OUTCOMES OF SNMMI "RARELY APPROPRIATE" PSMA PET/CT SCAN USE IN INITIAL STAGING AND BIOCHEMICALLY RECURRENT PROSTATE CANCER

被引：0
|
作者：
Bennett, Richard [1 ]
Li, Eric V. [1 ]
Ho, Austin Y. [1 ]
Aguiar, Jonathan [1 ]
Mahenthiran, Ashorne K. [1 ]
Kumar, Sai [1 ]
Suk-ouichai, Chalairat [1 ]
Neill Clayton [1 ]
Patel, Hiten D. [1 ]
Schaeffer, Edward M. [1 ]
Savas, Hatice [1 ]
Ross, Ashley E. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182
引用
收藏
页码：S77 / S78
页数：2
相关论文
共 50 条
  • [31] Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
    P. A. Glemser
    L. T. Rotkopf
    C. H. Ziener
    B. Beuthien-Baumann
    V. Weru
    A. Kopp-Schneider
    H. P. Schlemmer
    A. Dimitrakopoulou-Strauss
    C. Sachpekidis
    Cancer Imaging, 22
  • [32] Comparison of Ga-68 PSMA PET/CT and Multiparametric MRI for Initial Detection and Staging of Prostate Cancer
    Gauthaman, Dinesh Kumar
    Luthra, Karuna
    Lele, Vikram
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2024, 23 (02) : 79 - 87
  • [33] Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
    Glemser, P. A.
    Rotkopf, L. T.
    Ziener, C. H.
    Beuthien-Baumann, B.
    Weru, V
    Kopp-Schneider, A.
    Schlemmer, H. P.
    Dimitrakopoulou-Strauss, A.
    Sachpekidis, C.
    CANCER IMAGING, 2022, 22 (01)
  • [34] PSMA PET/CT for Primary Staging of Prostate Cancer- An Updated Overview
    Jochumsen, Mads Ryo
    Bouchelouche, Kirsten
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 39 - 45
  • [35] The role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer
    Bagguley, Dominic
    Ong, Sean
    Buteau, James P.
    Koschel, Sam
    Dhiantravan, Nattakorn
    Hofman, Michael S.
    Emmett, Louise
    Murphy, Declan G.
    Lawrentschuk, Nathan
    FUTURE ONCOLOGY, 2021, 17 (17) : 2225 - 2241
  • [36] COMPARING PSMA-PET/CT TO MPMRI AND HISTOPATHOLOGY FOR STAGING PROSTATE CANCER
    Berger, Israel
    Annabattula, Chandra
    Lewis, Jeffrey
    Shetty, Deepa V.
    Winter, Matthew
    Loh, Han
    Varol, Celi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 51 - 51
  • [37] PSMA-PET-CT for primary staging in patients with advanced prostate cancer
    Cappel, Cedric Curt
    Dopcke, Denise
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (03) : 257 - 260
  • [38] Management impact and detection rate of 18F-Prostate-Specific Membrane Antigen (18F-PSMA) PET/CT imaging for biochemically recurrent prostate cancer
    Panagiotidis, E.
    Paschali, A.
    Klampatsas, A.
    Pipintakou, A.
    Makridou, A.
    Chatzipavlidou, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S174 - S174
  • [39] BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: COULD PSMA PET/CT SCAN BE USEFUL?
    Carvalho, Joao
    Nunes, Pedro
    Lima, Joao
    Quaresma, Vasco
    Silva, Rodolfo
    Silva, Edgar
    Soeiro, Paula
    Parada, Belmiro
    Marconi, Lorenzo
    Costa, Gracinda
    Figueiredo, Arnaldo
    JOURNAL OF UROLOGY, 2020, 203 : E1107 - E1107
  • [40] Salvage radiotherapy of recurrent prostate cancer after PSMA PET/MRI and PET/CT
    Knudtsen, Ingerid S.
    Abrahamsen, Bendik S.
    Selnaes, Kirsten M.
    Langorgen, Sverre
    Keil, Thomas M.
    Johansen, Hakon
    Castillejo, Miguel J.
    Bogsrud, Trond V.
    Aarsaether, Erling J.
    Haugnes, Hege S.
    Tandstad, Torgrim
    Elschot, Mattijs
    Bathen, Tone F.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2391 - S2393
12345